(Q24245091)

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Blood transfusion. Iron load and retinopathy of prematurity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Long-acting erythropoietin: clinical studies and potential uses in neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Postnatal changes in erythropoietin levels in untransfused premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Changing patterns of red blood cell transfusion in very low birth weight infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Anemia of prematurity. Current concepts in the issue of when to transfuse.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Iron status and the treatment of the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

The use of erythropoietin in neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Single-dose darbepoetin administration to anemic preterm neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Current issues in neonatal transfusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Anemia of prematurity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Studies on the liver to kidney switch of erythropoietin production

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Erythropoietin therapy for premature infants: cost without benefit?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021

Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004865.PUB2

7 January 2021